Kathera Bioscience is excited to announce that it received a Fast Track SBIR grant from the National Institute of Allergy and Infectious Diseases to advance novel fungal-selective DHFR inhibitors to combat emerging?and?drug-resistant fungal infections. #innovation?#science?#technology?#biotech?#antifungal?#drug
Kathera Bioscience Inc.
生物技术研究
Union，New Jersey 276 位关注者
Developing Cutting Edge Antifungal Therapies
关于我们
Kathera Bioscience is developing therapies to treat fungal infections that are a major cause of human disease due to rising numbers of infections globally. KatheraBio aims to develop novel, broad spectrum drugs to overcome the limitations of current treatment options.
- 网站
-
https://www.katherabio.com
Kathera Bioscience Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 1 人
- 总部
- Union，New Jersey
- 类型
- 私人持股
- 创立
- 2020
地点
-
主要
获取路线
1000 Morris Ave
STEM Bldg Suite 5-13
US，New Jersey，Union，07083
Kathera Bioscience Inc.员工
-
Kurt Saionz, Ph.D.
Principal Scientist, Medicinal Chemistry
-
Stephen A. Parent, PhD
Biotech Startup Founder, Entrepreneur and Business Development Strategist
-
Robert E McLaughlin
VP of Research at Institute for Life Science Entrepreneurship / VP of Research at Kathera Bioscience
-
James Balkovec
Drug Discovery Expert Specializing in Anti-Infectives
动态
-
Kathera Bioscience is excited to announce that it received a Fast Track SBIR grant from the National Institute of Allergy and Infectious Diseases to advance novel fungal-selective DHFR inhibitors to combat emerging?and?drug-resistant fungal infections. #innovation?#science?#technology?#biotech?#antifungal?#drug
-
JOB ALERT: Kathera Bioscience Inc. is #hiring a Senior Scientist, Chemistry! Visit #BioNJ’s Career Portal and #apply today! Check back often as new jobs are posted daily. #NJJobs #career #resume #lifesciencejobs #jobalert #njjobs https://ow.ly/wgGN50Qle9q
-